Drug Shortage Report for FULVESTRANT INJECTION

Last updated on 2021-12-22 History
Report ID 130857
Drug Identification Number 02468549
Brand name FULVESTRANT INJECTION
Common or Proper name FULVESTRANT INJECTION
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) FULVESTRANT
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5ml
ATC code L02BA
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-01-06
Actual start date 2021-01-06
Estimated end date Unknown
Actual end date 2021-12-21
Shortage status Resolved
Updated date 2021-12-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-12-22 English Compare
v9 2021-12-21 French Compare
v8 2021-12-21 English Compare
v7 2021-03-23 French Compare
v6 2021-03-23 English Compare
v5 2021-02-03 French Compare
v4 2021-02-03 English Compare
v3 2021-01-07 English Compare
v2 2021-01-05 French Compare
v1 2021-01-05 English Compare

Showing 1 to 10 of 10